Skip to main content
SpringerLink
Log in

Bone remodelling in monoclonal gammopathies of uncertain significance, symptomatic and nonsymptomatic myeloma

  • Originals
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Summary

In order to characterize the abnormalities of bone remodelling in the various stages of plasma cell disorders, we studied 60 patients (29 monoclonal gammopathies of uncertain significance (MGUS), 13 stage I myeloma, 18 stage III myeloma). We carried out histomorphometric study of bone biopsies in 34 patients and measurement of osteocalcin and the calciuria/creatinine ratio.

Bone remodelling was approximately normal (BV/TV: 21.2±7, ES: 4.1±2, OS: 16.5±10) in MGUS. Stage I myeloma was characterised by parallel increases in resorption surfaces and osteoid surfaces (BV/TV: 18±5, ES/BS: 7.4±3.5, OS/BS: 24.8±11.5), of the ca/cr ratio and osteocalcin. In stage III myeloma, resorption surfaces and the ca/cr ratio showed an even greater increase while osteoid surfaces, osteocalcin and trabecular bone volume decreased (BV/TV 13.6±6, ES/BS: 12.1±6, OS/BS: 13.6±8.3). Osteocalcin and osteoid surfaces were correlated (r=0.5). There was a positive correlation between osteocalcin and the number of plasmocytes in stage 1 myeloma (r=0.64) and a negative correlation in stage III myeloma (r=0.9).

Bone remodeling was normal in MGUS; bone remodelling grew with a parallel increase of formation and resorption in stage I; bone resorption increased while bone formation decreased in stage III myeloma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mundy, G.R., Raisz, L.G., Cooper, R.A. et al. Evidence for the secretion of an osteoclast stimulating factor in myeloma. N Engl J Med 1974, 291, 1041–1046.

    PubMed  Google Scholar 

  2. Bataille, R., Chappard, D., Marcelli, C., Dessauw, P., Sany, J., Baldet, P., Alexandre, C. Mechanisms of bone destruction in multiple myeloma: the importance of an unbalanced process in determining the severity of lytic bone disease. J Clin Oncol 1989, 7, 1909–1914.

    PubMed  Google Scholar 

  3. Bataille, R., Chappard, D., Klein, B. Mechanisms of bone lesions in multiple myeloma. Hematol Oncol 1992, 6, 285–295.

    Google Scholar 

  4. Laroche, M., Cantagrel, A., Degraeve, J., Mazieres, B., Arlet, J. Avantages et inconvenients de l'étude de l'excrétion urinaire à jeun du calcium et du phosphore comparée aux dosages de 24 heures. Sem Hop Paris, 1988, 64, 81–84.

    Google Scholar 

  5. Nordin, B.E.C. Diagnosis procedures in disorders of calcium metabolism. Clin Endocrinol, 1978, 8, 56–67.

    Google Scholar 

  6. Parfitt, A.M., Drezner, M.K., Glorieux, F.H. et al. Bone histomorphometry: standardization of nomenclature symbols and units. J Bone Min Res 1987, 2, 595–610.

    Google Scholar 

  7. Meunier, P.J., Courpron, P., Edouard, C. et al. Physiological senile involution and pathological rarefaction of bone. Quantitative and comparative histological data. In: Clinics in Endocrinology and Metabolism, London, England, Saunders, 1973, 239–256.

    Google Scholar 

  8. Kyle, A. Classification and diagnosis of monoclonal gammopathies. In: Manual of Clinical Laboratory Immunology. Ed.: Rose, N.R., Friedman, H., Fahey, K., Washington (DC) American Society for Microbiology 1984, 152–167.

  9. Alexandre, C., Bataille, R., Chappard, D., Dessauw, P., Sany, J., Riffat, G. Apport de la biopsie osseuse avec histomorphométrie dans l'évaluation d'une gammapathie monoclonale. Rev Rhum 1987, 54, 717–721.

    PubMed  Google Scholar 

  10. Kyle, A. “Benign” monoclonal gammopathy - after 20 to 35 years of follow-up. Mayo Clin Proc 1993, 68, 26–36.

    PubMed  Google Scholar 

  11. Durie, B.G.M., Salmon, S.E. A clinical staging system for multiple myeloma. Cancer, 1975, 842–854.

  12. Dimopoulos, M.A., Moulopoulos, A., Smith, T., Delassale, K.B., Alexanian, R. Risk of disease progression in asymptomatic multiple myeloma. Am J Med 1993, 94, 57–61.

    PubMed  Google Scholar 

  13. Taube, T., Beneton, M.N.C., Mc Closley, E.V., Rogers, S., Greaves, M., Kanis, J.A. Abnormal bone remodelling in patients with myelomatosis and normal biochemical indices of bone resorption. Eur J Haematol 1992, 49, 192–198.

    PubMed  Google Scholar 

  14. Valentin-Opran, A., Charbon, S.A., Meunier, P.J. et al. Quantitative histology of myeloma-induced bone changes. Br J Haematol 1982, 52, 601–610.

    PubMed  Google Scholar 

  15. Bataille, R., Delmas, P.D., Chappard, D., Sany, J. Abnormal serum bone Gla protein levels in multiple myeloma. Cancer 1990, 66, 167–172.

    PubMed  Google Scholar 

  16. Brown, J.P., Delmas, P.D., Malaval, L., Edouard, C., Chapuy, M.C., Meunier, P.J. Serum bone Gla-protein: a specific marker for bone formation in post-menopausal osteoporosis. Lancet 1984, 1, 1091–1093.

    PubMed  Google Scholar 

  17. Delmas, P.D., Demiaux, B., Malaval, J. et al. Serum bone gamma carboxyglutamic acid-containing protein in primary hyperparathyroidism and in malignant hypercalcemia: comparison with bone histomorphometry. J Clin Invest 1986, 77, 985–991.

    PubMed  Google Scholar 

  18. Williams, A.T., Shearer, M.J., Oyeyi, J. et al. Serum osteocalcin in the management of myeloma: Eur J Cancer, 1993, 29A, 140–142.

    Google Scholar 

  19. Frost, H.M. Tetracyclin-based histological analysis of bone remodelling. Calc. Tissue Res 1969, 3, 211–237.

    Google Scholar 

  20. Baron, R., Chakraborty, D., Vhaterjee, W. et al. Biology of the osteoclast. In: Physiology and Pharmacology of Bone. Eds.: G.R. Mundy and T.J. Martin, Springer New York, 1993.

    Google Scholar 

  21. Delmas, P.D., Charon, S., Chapuy, M.C. et al. Long-term effects of dichloromethylene diphosphonate on skeletal lesions in multiple myeloma Metab Bone Dis Rel Res 1982, 4, 163–168.

    Google Scholar 

  22. Lahtinen, R., Laasko, M., Palva, I., Virkkunen, P., Elomaa, I. Randomised, placebo-controlled multicentre trial of clodronate in multiple myeloma. Lancet, 1992, 340, 1049–1052.

    PubMed  Google Scholar 

  23. Merlini, G., Attardo-Parinello, G., Piccinini, L. et al. Long-term effects of parenteral dichloromethylene biphosphonate on bone disease in myeloma patients treated with chemotherapy. Hematol Oncol. 1990, 8, 23–30.

    PubMed  Google Scholar 

  24. Roux, C., Ravaud, P., Cohen-Solal, M. et al. Biologic, histologic and densitometric effects of oral risedronate on bone patients with multiple myeloma. Bone 1994, 15, 41–49.

    PubMed  Google Scholar 

  25. Harley, J.B., Schilling, A., Glidewell, O. Ineffectiveness of fluoride therapy in multiple myeloma. N Engl J Med 1975, 286, 1283–1288.

    Google Scholar 

  26. Kyle, R.A., Jowsey, J., Kelly, P.J., Taves, D.R. Multiple myeloma bone disease. N Engl J Med 1975, 293, 13341338.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service de Rhumatologie, CHU Rangueil Toulouse, France

    M. Laroche

  2. Service d'hématologie, CHU Purpan Toulouse, France

    M. Attal

  3. Service de Rhumatologie, CHU Purpan Toulouse, France

    C. Dromer

Authors
  1. M. Laroche
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Attal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Dromer
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

The Midi-Pyrenees Myeloma Group

Rights and permissions

Reprints and permissions

About this article

Cite this article

Laroche, M., Attal, M., Dromer, C. et al. Bone remodelling in monoclonal gammopathies of uncertain significance, symptomatic and nonsymptomatic myeloma. Clin Rheumatol 15, 347–352 (1996). https://doi.org/10.1007/BF02230356

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02230356

Key words

Search

Navigation